Affimed in brief
Affimed is a listed company in the Biotechnology industry, based in Germany. Its last known market value was $92 M (July 2023); there is no current figure. In the year to Dec 2021 it had sales of $40 M and a net loss of $57 M. Its shares trade under the symbol A28.F (Frankfurt).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
Rank in Germany: #303 (Jan 2020) · #229 (Jan 2021) · #240 (Jan 2022) · #296 (Dec 2022) · #362 (Jul 2023)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- -142.5%
- Operating margin
- —
- Return on equity
- -42.2%
- Liabilities / assets
- 39.6%
Annual results
- Revenue
- $40 M
- Operating income
- —
- Net income
- $-57 M
Dec-2021 ending year
Balance sheet
- Total assets
- $225 M
- Total liabilities
- $89 M
- Total equity
- $135 M
Dec-2021 ending year
How Affimed compares in Biotechnology
- Revenue$40 M · higher than 57% of 647
- Net margin-142.5% · higher than 36% of 408
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Affimed🇩🇪 | $92 M | — | -142.5% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jul 30, 2023 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Profile updated:
- Nov 4, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Affimed? Verify and update this profile — free
Show Affimed's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.